Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients
- Status
- TERMINATED
- Phase
- PHASE2
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)
- Status
- COMPLETED
- Phase
- PHASE3
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals
- Status
- COMPLETED
- Phase
- PHASE2
Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
- Status
- COMPLETED
- Phase
- PHASE3
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose
- Status
- COMPLETED
- Phase
- PHASE4
Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
- Status
- TERMINATED
- Phase
- PHASE2
The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
- Status
- COMPLETED
- Phase
- PHASE1
The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
- Status
- COMPLETED
- Phase
- PHASE3
The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell
- Status
- COMPLETED
- Phase
- NA
An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease
- Status
- COMPLETED
- Phase
- PHASE3
The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3
- Status
- COMPLETED
- Phase
- PHASE2